openPR Logo
Press release

Viral Inactivation Market Set to Surge Significantly During 2025

09-28-2017 01:25 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Viral Inactivation Market Set to Surge Significantly During

As per a report by Transparency Market Research, the global viral inactivation market will likely rise at a healthy 7.4% during the period between 2017 and 2025. Rising at this rate, the market will likely become worth US$5.736 bn by 2025 from US$3.05 bn in 2016.

Various methods have been developed and many more are under trial for viral inactivation during biopharmaceutical production and for blood and blood derived products. Depending upon the methods, the main segments of the global viral inactivation market are chemical, radiation, and others such as pasteurization, dry and moist heat treatment. Among them, the segment of radiation method for viral inactivation will likely outpace all others vis-à-vis growth rate in the near future because of the increasing uptake of UV-radiation equipment by the blood centers in developed countries of the U.S., the U.K, Germany, France, Italy, etc.

View and Download TOC of Viral Inactivation Market Research Report@

Depending upon geography, the key segments of the global viral inactivation market are North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Of them, North America holds a leading share in the market on account of solid demand for blood and blood products and vaccine in this region. The market in the region is predicted to rake in a revenue of US$2.31 bn by 2025.

New Drugs Approval Boosts Chances to Earn Higher Revenue

Approval of new drugs, regulatory guidelines framed by regulatory authorities for the viral safety of biologics products, and rapid growth of biologics and biosimilars industry are slated to provide a major impetus to the global market for viral inactivation.

“The demand for biosimilars products has growing rapidly in both developed and developing countries due to need for cost effective generic treatment alternative to high cost branded biologics. In fact, biopharmaceutical products worth over hundreds of billions of dollars will go off patents in the near future and this will provide a major boost to the market,” explains the lead analyst of the report.

Besides the increasing occurrence of infectious diseases and growing application of biosimilars therapeutic treatment for a range of diseases will also serve to have a positive influence on the market.

Development of Vaccines for New Viruses to Provide Avenues for Growth

Posing a challenge to the market, on the flipside, is the steep cost of developing and manufacturing biologics and biosimilars products and also the expensiveness of equipment for viral inactivation. However, emergence of new viruses and development of vaccines against these viruses and development and adoption of newer viral inactivation methods is expected to open up new avenues of growth in the market.

This review is based on the findings of a TMR report, titled, “Viral Inactivation Market (Method – Chemical and Radiation; Application – Blood and Blood Products, Vaccines, and Cell and Tissue Culture; End-user - Pharmaceutical and Biotechnology Companies, Blood Banks and Hospitals, and Contract Research Organizations) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017–2025.”

Request and Download Sample Report@

Some of the dominant players in the global market for viral inactivation are Shandong Weigao Group Medical Polymer Company Limited, Merck & Co, Sartorius AG, Cerus Corporation, Macopharma SA, Terumo BCT, Inc., Thermo Fisher Scientific Inc., and V.I.P.S. SA. Merck & Co., Inc. among them, held a leading share in the market in 2016. The reasons behind its dominant position are a solid geographical outreach and strategic acquisitions.

Other keen companies operating in the global market for viral inactivation are also leveraging carefully-considered acquisitions to bolster their positions. They are also expending time and money into development of new products to cater to the different needs of the population.

Buy Full Viral Inactivation Market Report@<ype=S

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Viral Inactivation Market Set to Surge Significantly During 2025 here

News-ID: 746143 • Views: 199

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases

More Releases for Viral

Viral Conjunctivitis Market- Pipeline Review, H1 2020
A new research document is added in HTF MI database of 50 pages, titled as 'Viral Conjunctivitis - Pipeline Review, H1 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions like North America, Europe or Asia and important players/vendors such as Adenovir Pharma AB, Invirsa Inc, IVIEW Therapeutics Inc, NanoViricides Inc, Okogen Inc, Panoptes Pharma GesmbH, Starpharma Holdings Ltd, TGV-Inhalonix Inc. The
Viral Vaccines Market : Challenges and Opportunities Against Viral Diseases
Vaccines are biotic compositions. They are basically formulated from living beings that increase the resistance against a specific illness. Vaccinations that help in avoiding the occurrence of specific diseases are known as prophylactic vaccines and in other instance, the vaccines that are helpful in treating the disease are called therapeutic vaccines. A vaccine is generally produced by using a weakened or murdered type of the sickness causing microorganism. The agent
Viral Inactivation - Global Market Outlook (2017-2023)
The latest industry research report on Viral Inactivation by MRC provides a thorough analysis of the global Viral Inactivation market. The report scrutinizes the market by different segments including regions, applications, competitive landscape, etc. over the predicted time frame. This report provides 360 Degree perspective of the Viral Inactivation industry with an all-inclusive discussion of definitions, classifications, and market players in the industry chain structure. It features qualitative and quantitative
Global Viral Molecular Diagnostics Market
The Viral Molecular Diagnostics Market reportprovides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease. Viral molecular diagnostic helps in
Fzillion Goes 'VIRAL' with itsLatest Additions
Both Quality and Quantity - How Fzillion has made it possible The world is known online retailer Fzillion is now showcasing the very best of the fashion world. Just recently the store has added the newest men and kids apparel to its extensive collection. Fzillion gives you a wide range of items, ranging from high prices to low prices, from winger collections to summer collections, from everyday casual wear to the
Detecting and Preventing Viral Contamination of Food
Foodborne viral outbreaks are ever present in the media spotlight. The European Food Safety Authority (EFSA) reported that viral agents were responsible for 11.9% of the foodborne outbreaks in the European Union (EU) during 2007, coming second only to Salmonella as the most common causation agent group. Undetected food contamination Foodborne viral infections often go undetected and differ from bacterial infections in that, once present in food, viruses will neither alter the